The parametric response map is an imaging biomarker for early cancer treatment outcome.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 19377487.
- Also identified by DOI 10.1038/nm.1919 and PMC identifier 3307223.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Here we describe the parametric response map (PRM), a voxel-wise approach for image analysis and quantification of hemodynamic alterations during treatment for 44 patients with high-grade glioma. Relative cerebral blood volume (rCBV) and flow (rCBF) maps were acquired before treatment and after 1 and 3 weeks of therapy. We compared the standard approach using region-of-interest analysis for change in rCBV or rCBF to the change in perfusion parameters on the basis of PRM (PRM(rCBV) and PRM(rCBF)) for their accuracy in predicting overall survival. Neither the percentage change of rCBV or rCBF predicted survival, whereas the regional response evaluations made on the basis of PRM were highly predictive of survival. Even when accounting for baseline rCBV, which is prognostic, PRM(rCBV) proved more predictive of overall survival.
Medical subject headings
- Biomarkers, Tumor
- Brain Neoplasms
- Glioma
- Magnetic Resonance Imaging
- Neoplasms